Vermillion Resolves Non-Contingent Claims with Bio-Rad; Vermillion to be Returned More Than $1M from Escrow

Vermillion, Inc.

has resolved all four of the non-contingent contract claims with Bio-Rad Laboratories, Inc.

arising from the sale to Bio-Rad of Vermillion's protein research tools and collaborative services business in November 2006. In exchange for a final settlement of the non-contingent claims, Bio-Rad will receive $700,000 from an escrow account established by Vermillion for the sale transaction. Vermillion will be returned approximately $1,080,000 from the escrow account, with $50,000 remaining in escrow as security for Bio-Rad's contingent indemnity claim in respect to the parties' litigation with Molecular Analytical Systems.